Skip to main content
Premium Trial:

Request an Annual Quote

HiberGene Garners CE Mark for MDx System

NEW YORK (GenomeWeb) – HiberGene said today that it has received CE marking for its HG Swift instrument for molecular diagnosis of infectious diseases.

The instrument is designed exclusively for use with the Dublin, Ireland-based company's portfolio of molecular infectious disease assays, including its recently launched HG Meningococcus, a test for bacterial meningitis, and its forthcoming HG GBS, a rapid test for Group B Streptococcus.

All of HiberGene's assays use loop-mediated isothermal amplification, and can provide results in less than an hour. The HG Swift instrument features a small footprint and compact hardware, and is ideal for labs with space constraints and for near-patient testing, HiberGene said. It features touchscreen operation and wireless communication capability.